Out now in @nejm.org, @lucamaini.bsky.social, @michaelannica.bsky.social, Pragya Kakani, and I analyze the opportunities and challenges associated with GENEROUS, the Trump Admin's most-favored-nation drug pricing model in Medicaid. www.nejm.org/doi/full/10....
A new pilot Medicaid program — GENEROUS — combines centralized pharmaceutical-coverage negotiations with most-favored-nation pricing in an effort to lower drug costs, but it has some limitations.
